Log In
Print this Print this


Also known as: ProfileQuant WT1

  Manage Alerts
Collapse Summary General Information
Company Qiagen N.V.
DescriptionReal-time quantitative polymerase chain reaction (qPCR) in vitro diagnostic test that measures specific target gene expression relative to ABL gene expression levels
Molecular Target Wilms tumor 1 (WT1)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsAid to monitor early treatment response and minimal residual disease (MRD) in acute myeloid leukemia (AML) patients; Quantify expression of the meningioma-1 (MN1) gene in patients with cytogenetically normal AML
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today